Tongji Hospital: Carcinoma trials

The registry lists 12 Carcinoma studies with Tongji Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 2Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence SurveillanceRecruitingNCT06653062
• Donafenib Combined With Immunotherapy and Local Therapy for Unresectable Hepatocellular Carcinoma That Has Failed in Previous TherapyNot yet recruitingNCT06496815Phase 4
• A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the OvaryRecruitingNCT06279104
• A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical ResectionNot yet recruitingNCT06089382Phase 3
• Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular InvasionNot yet recruitingNCT06089369Phase 3
• Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular CarcinomaRecruitingNCT05717738
• Comparing Laparoscopic and Open Surgery for Pancreatic CarcinomaRecruitingNCT03785743Not applicable
• Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCCStatus unknownNCT05420922
• Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular CarcinomaCompletedNCT05178524Not applicable
• Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical StudyStatus unknownNCT05028231
• Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell CarcinomaCompletedNCT04735861Phase 2
• The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular CarcinomaCompletedNCT04303286